202537 people have viewed this drug in the last 60 days
Updated 2025-10-03
| Last Update | 2022-12-12 |
| Register Year | 2021 |
| Product Type | Human |
| Drug Type | Biological |
| Scientific Name | DURVALUMAB |
| Trade Name | IMFINZI 120 mg / 2.4 ml |
| Strength Unit | mg/ml |
| Pharmaceutical Form | Solution for infusion |
| Administration Route | Intravenous use |
| Atc Code1 | L01XC28 |
| Atc Code2 | |
| Size | 2.4 |
| Size Unit | ml |
| Package Types | Vial |
| Package Size | 1 |
| Legal Status | Prescription |
| Product Control | Uncontrolled |
| Distribute Area | Hospital |
| Public price | $2843.45 |
| Shelf Life | 24 Months |
| Marketing Company | AstraZeneca UK Limited |
| Marketing Country | United Kingdom |
| Manufacture Name | AstraZeneca Pharmaceuticals LP |
| Manufacture Country | United States |
| Secondry package manufacture | |
| Main Agent | SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO) |
| Secosnd Agent | ALNAGHI COMPANY |
| Third Agent | |
| Visits | 202537 |
Do not forget, after purchasing the medicine, help us determine the price more accurately, press the button below and adjust the price directly
| Name | Price | Visits | Updated |
|---|---|---|---|
| IMFINZI 500 mg / 10 ml | $11784.85 | 101618 visits | 2022-12-12 |
| IMFINZI 120 mg / 2.4 ml | $2843.45 | 202537 visits | 2022-12-12 |